Safety of inhaled proteins for therapeutic use.

Safety of inhaled proteins for therapeutic use.

Item
http://www.wikidata.org/entity/Q33646192
The lung as a route for systemic delivery of therapeutic proteins and peptidesInhaled insulin: overview of a novel route of insulin administration.Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications.Carrier-based strategies for targeting protein and peptide drugs to the lungs.The History of Therapeutic Aerosols: A Chronological Review.Novel devices for individualized controlled inhalation can optimize aerosol therapy in efficacy, patient care and power of clinical trials.Regulatory toxicology considerations for the development of inhaled pharmaceuticals.Inhaled biopharmaceutical drug development: nonclinical considerations and case studies.Bioavailability of therapeutic proteins by inhalation--worker safety aspects.Alveolar macrophages are a primary barrier to pulmonary absorption of macromolecules.Pulmonary Delivery of Magnetically Targeted Nano-in-Microparticles.Will pulmonary drug delivery for systemic application ever fulfill its rich promise?Q58877305
P2860

Safety of inhaled proteins for therapeutic use.

Item
http://www.wikidata.org/entity/Q33646192
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Safety of inhaled proteins for therapeutic use.
@ast
Safety of inhaled proteins for therapeutic use.
@en
type
label
Safety of inhaled proteins for therapeutic use.
@ast
Safety of inhaled proteins for therapeutic use.
@en
prefLabel
Safety of inhaled proteins for therapeutic use.
@ast
Safety of inhaled proteins for therapeutic use.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Safety of inhaled proteins for therapeutic use.
@en
P2093
P304
P31
P356
P433
P478
P577
P698